[Present and future of vaccines]

Area of Science:

• Vaccinology and immunology
• Biotechnology and biopharmaceutical production
• Public health and infectious disease control

Context:

• Current vaccine development faces challenges in efficacy, safety, and cost.
• Regulatory frameworks like the Drugs and Cosmetics Act and Good Manufacturing Practices (GMP) ensure vaccine quality.
• Ongoing research addresses limitations of existing vaccines and production methods.

Purpose:

• To review the history and current status of vaccine development.
• To highlight challenges and areas for improvement in vaccine technology and production.
• To explore emerging vaccine candidates and novel applications.

Summary:

• The review traces vaccine development history, noting existing challenges in efficacy, safety, and cost.
• It details regulatory standards (Drugs and Cosmetics Act, Minimum Requirement of Biological Products, GMP) for vaccine quality.
• Emerging vaccine technologies (DNA vaccines, mucosal vaccines) and applications (cancer, autoimmune diseases) are discussed.

Impact:

• Informs researchers and policymakers about the evolving landscape of vaccine development.
• Highlights the potential of new technologies to address unmet medical needs.
• Provides a foundation for future advancements in prophylactic and therapeutic vaccines.